Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bloch, Katyrzyna"'
Autor:
Siddiqui, Moneeza K., Maroteau, Cyrielle, Veluchamy, Abirami, Tornio, Aleksi, Tavendale, Roger, Carr, Fiona, Abelega, Ngu-Uma, Carr, Dan, Bloch, Katyrzyna, Hallberg, Pär, Yue, Qun-Ying, Pearson, Ewan R., Colhoun, Helen M., Morris, Andrew D., Dow, Eleanor, George, Jacob, Pirmohamed, Munir, Ridker, Paul M., Doney, Alex S. F., Alfirevic, Ana, Wadelius, Mia, Maitland-van der Zee, Anke-Hilse, Chasman, Daniel I., Palmer, Colin N. A.
Publikováno v:
K Siddiqui, M, Maroteau, C, Veluchamy, A, Tornio, A, Tavendale, R, Carr, F, Abelega, N-U, Carr, D, Bloch, K, Hallberg, P, Yue, Q-Y, Pearson, E R, Colhoun, H M, Morris, A D, Dow, E, George, J, Pirmohamed, M, Ridker, P M, Doney, A S F, Alfirevic, A, Wadelius, M, Maitland-van der Zee, A-H & Chasman, D I & Palmer, C N A 2017, ' A common missense variant of LILRB5 is associated with statin intolerance and myalgia ', European Heart Journal, vol. 38, no. 48, pp. 3569–3575 . https://doi.org/10.1093/eurheartj/ehx467
European heart journal, 38(48), 3569-3575. Oxford University Press
European heart journal, 38(48), 3569-3575. Oxford University Press
Aims: A genetic variant in LILRB5 (leukocyte immunoglobulin-like receptor subfamily-B) (rs12975366: T > C: Asp247Gly) has been reported to be associated with lower creatine phosphokinase (CK) and lactate dehydrogenase (LDH) levels. Both biomarkers ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::815d0b05b63f6fab25b392f04bbdedbc
https://hdl.handle.net/20.500.11820/4b9b5829-1e58-4925-a566-c1df88b1f51b
https://hdl.handle.net/20.500.11820/4b9b5829-1e58-4925-a566-c1df88b1f51b
Autor:
K Siddiqui M; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Maroteau C; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Veluchamy A; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Tornio A; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Tavendale R; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Carr F; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Abelega NU; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Carr D; Institute of Translation Medicine, University of Liverpool, Liverpool L69 3BX, UK., Bloch K; Institute of Translation Medicine, University of Liverpool, Liverpool L69 3BX, UK., Hallberg P; Department of Medical Sciences, Clinical Pharmacology and Science of Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Yue QY; Medical Products Agency, Dag Hammarskjölds väg 42, 75237 Uppsala, Sweden., Pearson ER; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK., Colhoun HM; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK.; Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK., Morris AD; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK.; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh EH4 2XU, UK., Dow E; Ninewells Hospital and Medical School, Dundee DD19SY, UK., George J; Ninewells Hospital and Medical School, Dundee DD19SY, UK., Pirmohamed M; Institute of Translation Medicine, University of Liverpool, Liverpool L69 3BX, UK., Ridker PM; Brigham and Women's Hospital, Department of Medicine, Preventive Medicine, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Doney ASF; Ninewells Hospital and Medical School, Dundee DD19SY, UK., Alfirevic A; Institute of Translation Medicine, University of Liverpool, Liverpool L69 3BX, UK., Wadelius M; Department of Medical Sciences, Clinical Pharmacology and Science of Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden., Maitland-van der Zee AH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, 3508 TB Utrecht, The Netherlands.; Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands., Chasman DI; Brigham and Women's Hospital, Department of Medicine, Preventive Medicine, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Palmer CNA; Pat McPherson Centre for Pharmacogenetics & Pharmacogenomics, Division of Molecular & Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee DD19SY, UK.
Publikováno v:
European heart journal [Eur Heart J] 2017 Dec 21; Vol. 38 (48), pp. 3569-3575.
